• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肢端肥大症管理指南:更新版

Guidelines for acromegaly management: an update.

作者信息

Melmed S, Colao A, Barkan A, Molitch M, Grossman A B, Kleinberg D, Clemmons D, Chanson P, Laws E, Schlechte J, Vance M L, Ho K, Giustina A

机构信息

Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.

出版信息

J Clin Endocrinol Metab. 2009 May;94(5):1509-17. doi: 10.1210/jc.2008-2421. Epub 2009 Feb 10.

DOI:10.1210/jc.2008-2421
PMID:19208732
Abstract

OBJECTIVE

The Acromegaly Consensus Group reconvened in November 2007 to update guidelines for acromegaly management.

PARTICIPANTS

The meeting participants comprised 68 pituitary specialists, including neurosurgeons and endocrinologists with extensive experience treating patients with acromegaly. EVIDENCE/CONSENSUS PROCESS: Goals of treatment and the appropriate imaging and biochemical and clinical monitoring of patients with acromegaly were enunciated, based on the available published evidence.

CONCLUSIONS

The group developed a consensus on the approach to managing acromegaly including appropriate roles for neurosurgery, medical therapy, and radiation therapy in the management of these patients.

摘要

目的

肢端肥大症共识小组于2007年11月再次召开会议,以更新肢端肥大症管理指南。

参与者

与会者包括68名垂体专家,其中有神经外科医生和内分泌学家,他们在治疗肢端肥大症患者方面经验丰富。

证据/共识过程:基于已发表的现有证据,阐明了肢端肥大症患者的治疗目标以及适当的影像学、生化和临床监测方法。

结论

该小组就肢端肥大症的管理方法达成了共识,包括神经外科手术、药物治疗和放射治疗在这些患者管理中的适当作用。

相似文献

1
Guidelines for acromegaly management: an update.肢端肥大症管理指南:更新版
J Clin Endocrinol Metab. 2009 May;94(5):1509-17. doi: 10.1210/jc.2008-2421. Epub 2009 Feb 10.
2
Consensus statement: medical management of acromegaly.共识声明:肢端肥大症的医学管理
Eur J Endocrinol. 2005 Dec;153(6):737-40. doi: 10.1530/eje.1.02036.
3
A consensus on criteria for cure of acromegaly.关于肢端肥大症治愈标准的共识。
J Clin Endocrinol Metab. 2010 Jul;95(7):3141-8. doi: 10.1210/jc.2009-2670. Epub 2010 Apr 21.
4
Pituitary function: Acromegaly: where are we now?垂体功能:肢端肥大症:我们目前的进展如何?
Nat Rev Endocrinol. 2009 Aug;5(8):420-2. doi: 10.1038/nrendo.2009.143.
5
Acromegaly: an endocrine society clinical practice guideline.肢端肥大症:内分泌学会临床实践指南。
J Clin Endocrinol Metab. 2014 Nov;99(11):3933-51. doi: 10.1210/jc.2014-2700. Epub 2014 Oct 30.
6
Canadian consensus guidelines for the diagnosis and management of acromegaly.加拿大肢端肥大症诊断与管理共识指南。
Clin Invest Med. 2006 Feb;29(1):29-39.
7
Diagnosis and treatment of acromegaly and its complications: consensus guidelines.肢端肥大症及其并发症的诊断与治疗:共识指南
J Endocrinol Invest. 2005;28(11 Suppl International):43-7.
8
Expert consensus document: A consensus on the medical treatment of acromegaly.专家共识文件:关于肢端肥大症治疗的共识。
Nat Rev Endocrinol. 2014 Apr;10(4):243-8. doi: 10.1038/nrendo.2014.21. Epub 2014 Feb 25.
9
[Consensus on the change of criteria for cure of acromegaly during the last decade].[过去十年间肢端肥大症治愈标准变化的共识]
Orv Hetil. 2011 May 1;152(18):703-8. doi: 10.1556/OH.2011.29092.
10
Criteria for cure of acromegaly: a consensus statement.肢端肥大症治愈标准:一项共识声明。
J Clin Endocrinol Metab. 2000 Feb;85(2):526-9. doi: 10.1210/jcem.85.2.6363.

引用本文的文献

1
Factors Influencing Hormone Remission in Growth Hormone-Secreting Pituitary Neuroendocrine Tumors With Residual Tumor: A Retrospective Cohort Study.影响伴有残留肿瘤的生长激素分泌型垂体神经内分泌肿瘤激素缓解的因素:一项回顾性队列研究
CNS Neurosci Ther. 2025 Aug;31(8):e70574. doi: 10.1111/cns.70574.
2
IGF-I levels during standard Lanreotide dose predicts biochemical outcome of high-frequency regimen in acromegaly.标准剂量兰瑞肽治疗期间的胰岛素样生长因子-I水平可预测肢端肥大症高频治疗方案的生化疗效。
Pituitary. 2024 Dec 26;28(1):7. doi: 10.1007/s11102-024-01479-9.
3
Differential gene expression and pathway analysis in growth hormone-secreting pituitary tumors according to granulation pattern.
根据颗粒化模式对生长激素分泌型垂体瘤进行差异基因表达和通路分析。
Front Oncol. 2024 Jul 30;14:1423606. doi: 10.3389/fonc.2024.1423606. eCollection 2024.
4
A Review on Coexisting Giants: The Interplay Between Acromegaly and Diabetes Mellitus.并存的巨人:肢端肥大症与糖尿病之间的相互作用综述
Cureus. 2024 Jul 9;16(7):e64165. doi: 10.7759/cureus.64165. eCollection 2024 Jul.
5
Concurrent Papillary Craniopharyngioma and Growth Hormone-Secreting Pituitary Adenoma: A Rare and Aggressive Collision Tumor.并发乳头型颅咽管瘤和生长激素分泌型垂体腺瘤:一种罕见且侵袭性的碰撞瘤。
AACE Clin Case Rep. 2024 Apr 16;10(4):144-148. doi: 10.1016/j.aace.2024.04.003. eCollection 2024 Jul-Aug.
6
Copeptin after pituitary surgery: is it worth measuring?垂体手术后的 copeptin:是否值得检测?
Pituitary. 2024 Oct;27(5):429-432. doi: 10.1007/s11102-024-01418-8. Epub 2024 Jul 16.
7
Excess endocrine growth hormone in acromegaly promotes the aggressiveness and metastasis of triple-negative breast cancer.肢端肥大症中过量的内分泌生长激素会促进三阴性乳腺癌的侵袭性和转移。
iScience. 2024 Jun 9;27(7):110137. doi: 10.1016/j.isci.2024.110137. eCollection 2024 Jul 19.
8
Pituitary tumor centers of excellence (PTCOE): the next border of acromegaly treatment.垂体瘤卓越中心(PTCOE):肢端肥大症治疗的新前沿
Pituitary. 2024 Aug;27(4):314-316. doi: 10.1007/s11102-024-01416-w. Epub 2024 Jun 25.
9
Surgical and non-surgical interventions for primary and salvage treatment of growth hormone-secreting pituitary adenomas in adults.成人生长激素分泌性垂体腺瘤的主要和挽救治疗的手术和非手术干预。
Cochrane Database Syst Rev. 2024 Feb 6;2(2):CD013561. doi: 10.1002/14651858.CD013561.pub2.
10
The Fascinating Interplay between Growth Hormone, Insulin-Like Growth Factor-1, and Insulin.生长激素、胰岛素样生长因子-1 和胰岛素之间的迷人相互作用。
Endocrinol Metab (Seoul). 2024 Feb;39(1):83-89. doi: 10.3803/EnM.2024.101. Epub 2024 Jan 9.